Key Takeaway: Kate Duvall has been appointed as the Corporate Controller at Fate Therapeutics, where she will manage accounting operations, financial reporting, and compliance. She previously worked as an auditor at Ernst & Young, specializing in life sciences and healthcare. Duvall is a Certified Public Accountant and holds a degree in accounting from the University of San Diego.
Price reaction · baseline $1.215 (2025-02-26T15:04:00.000Z) · hit during market hours · 2 other FATE headline(s) in the window, move may be shared
day 0 close · peak
-4.5%
Market Sentiment Analysis
POSITIVE FACTORS
Kate Duvall has extensive experience in accounting operations.
She is a Certified Public Accountant, adding credibility to her role.
Her background includes work with prestigious clients at Ernst & Young.
Full Press Release Details
Kate Duvall is Corporate Controller at Fate Therapeutics and is responsible for overseeing accounting operations and technical accounting, financial reporting, and SOX compliance. Prior to joining Fate, Ms. Duvall served as an auditor at Ernst & Young LLP for clients in the life sciences, health care, and retail industries. Ms. Duvall is a Certified Public Accountant in the State of California. She holds a bachelor’s degree in accounting from the University of San Diego.
Frequently Asked Questions
What is Kate Duvall's role at Fate Therapeutics?
Kate Duvall is the Corporate Controller responsible for accounting operations.
Where did Kate Duvall work before Fate Therapeutics?
She served as an auditor at Ernst & Young LLP.
What qualifications does Kate Duvall have?
She is a Certified Public Accountant and holds a degree in accounting.
Which industries did Duvall audit at Ernst & Young?
She worked with clients in life sciences, healthcare, and retail.